aureus infection and Selleckchem Idarubicin stroke patients infected by other organisms. HT of ischemic stroke was seen more commonly in PVE caused by S. aureus than by other pathogens (67% vs. 35%). Platelet count was much lower with S. aureus infection, which may indicate a possible role of sepsis in the development of HT of ischemic stroke. Therefore, results from the present study support

the discontinuation of anticoagulant therapy in patients with PVE caused by S. aureus due to the high occurrence of HT of embolic stroke seen in our data. The main limitation of this study was the small patient population and retrospective analysis. Limited number of cases may have Inhibitors,research,lifescience,medical caused the negative results Inhibitors,research,lifescience,medical seen here. Clinical detection alone of embolic stroke clearly underestimates the true prevalence. Furthermore, many of the patients diagnosed with IE and ischemic stroke simultaneously at the time of hospital admission likely had echocardiographic examinations performed at varying stages of endocarditis development. Therefore, the predictive value of echocardiography for stroke and HT may be limited. Further prospective studies to define parameters of HT should be implemented in a

larger population to help clarify the optimal care of PVE patients with ischemic stroke. In conclusion, although we identified Inhibitors,research,lifescience,medical patients through a multicenter study, a limited number of cases likely impacted the negative results seen here. However, a large number of patients with PVE who suffered a stroke subsequently had HT. Therefore, further studies to define predictive parameters of HT should be implemented in a larger population. Acknowledgements This study was supported by a grant Inhibitors,research,lifescience,medical of the Korea Society of Echocardiography Inhibitors,research,lifescience,medical (2011) and Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (MSIP)

(No.2012027176).
REFER TO THE PAGE 116-122 Since the first report by Dote et al.,1) stress-induced cardiomyopathy (SCMP) also called Takotsubo cardiomyopathy, transient left ventricular apical ballooning, or broken heart syndrome, has been increasingly recognized. SCMP is characterized by transient mid- and apical-segment left ventricular dysfunction in the absence of significant angiographic coronary stenosis, and it primarily affects postmenopausal also women after psychological or physical stress. Clinically, SCMP is characterized by a combination of sudden-onset chest pain or dyspnea, an abnormal electrocardiogram (ECG) with ST-segment elevation and T-wave changes, and positive cardiac biomarkers mimicking acute myocardial infarction.2) Therefore, SCMP should be considered in the differential diagnosis of acute myocardial infarction. Over the years, the criteria for the diagnosis of SCMP have evolved and the recent criteria were proposed by the Mayo Clinic in 2008.